Major adverse kidney events predict reduced survival in ventricular assist device supported patients
ConclusionsMAKE significantly impacts survival. In our cohort, MAKE was predicted by post-implant right ventricular failure and chronic haemolysis. The lack of early eGFR improvement on VAD support may indicate higher risk for MAKE.
Source: ESC Heart Failure - Category: Cardiology Authors: Sumita Barua,
Sean M. Conte,
Callum Cherrett,
Katherine L. Kearney,
Desiree Robson,
Christopher Bragg,
Peter S. Macdonald,
Kavitha Muthiah,
Christopher S. Hayward Tags: Original Article Source Type: research
More News: Biochemistry | Cardiology | Chronic Kidney Disease | Heart | Heart Failure | Urology & Nephrology